When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
YJ - Why Nuvve Holding Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga
Yunji Inc.
Gainers
Shift Technologies, Inc. (NASDAQ: SFT) shares climbed 107.8% to $0.2239. Shift Technologies recently said it will file for Chapter 11 bankruptcy protection.
Treasure Global Inc. (NASDAQ: TGL) climbed 65.1% to $0.5150 after the company announced an AI robot designed to conduct extended-hour live commerce sessions on TikTok.
SeaStar Medical Holding Corporation (NASDAQ: ICU) shares climbed 45.3% to $0.6589 after the FDA granted the company’s Selective Cytopheretic Device Breakthrough Device Designation for hepatorenal syndrome.
RVL Pharmaceuticals plc (NASDAQ: RVLP) shares gained 31.4% to $0.0670 after falling 12% on Tuesday. RVL Pharmaceuticals said on Oct. 12, the company received delisting notice from Listing Qualifications Department of Nasdaq Stock Market LLC.
Falcon's Beyond Global, Inc. (NASDAQ: FBYD) climbed 30.2% to $15.95.
Spirit AeroSystems Holdings, Inc. (NYSE: SPR) surged 24.6% to $21.42 after the company announced it reached an agreement with Boeing to support production stability. The company also issued guidance.
Outlook Therapeutics, Inc. (NASDAQ: OTLK) gained 24% to $0.4920.
Biocept, Inc. (NASDAQ: BIOC) shares climbed 23.3% to $0.63 after falling over 6% on Tuesday. Biocept recently filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware.
Secoo Holding Limited (NASDAQ: SECO) jumped 21.5% to $1.3499.
Baudax Bio, Inc. (NASDAQ: BXRX) gained 19.7% to $0.2395 after issuing a corporate update. The company said Phase 1/2a clinical study of TI-168 in Hemophilia A with FVIII inhibitors is projected to begin in the first quarter.
Avalon GloboCare Corp. (NASDAQ: ALBT) rose 15.9% to $0.8693. Avalon GloboCare partnered with Qi Diagnostics Limited to co-develop international multi-center clinical studies for DKAir™ breathalyzer device for the early detection of diabetic ketoacidosis.